Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL19P14 is a processed pseudogene corresponding to the ribosomal protein L19 gene (RPL19). Pseudogenes such as RPL19P14 are sequences in the genome that closely resemble known protein-coding genes but typically contain disruptive mutations or lack regulatory elements, rendering them non-functional. As a pseudogene, RPL19P14 does not code for a functional protein, and it is not considered a therapeutic target[1][2][11]. The functional RPL19 gene encodes a component of the 60S subunit of cytoplasmic ribosomes, but the pseudogene's biological role—if any—is not established[4][5]. Thus, RPL19P14 is not used in drug targeting, biomarker development, or disease association. Notes: - This entry is not a functional gene or target and does not have defined biological function, involvement in molecular pathways, or relevance to disease or therapeutics[1][2][5][11]. - The main RPL19 gene is different: it codes for a ribosomal protein with clear biological and disease relevance, but RPL19P14 itself does not[4][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L19 pseudogene 14 (RPL19P14).